7 Papers
24 Citations
Jun Yao is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Hepatitis B & Cirrhosis. The author has an hindex of 3, co-authored 7 publications.
Chat about Author
Papers
The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010.
TL;DR: A single booster dose with 3 doses of HepB with 5 or 10 µg are effective in generating protective antibody against HBV; however, for anti-HBs-negative children after a single dose of booster, 3 doses are needed.
14
The correlation between serum cytokine levels and liver cirrhosis in chronic hepatitis B patients: A meta-analysis
Gaofeng Cai,Zhengting Wang,Jun Yao,Kui Liu,Zhifang Wang,Yongdi Chen,Huakun Lv,Biao Zhou,Chonggao Hu +8 more
- 25 Oct 2018
TL;DR: A meta-analysis evaluating whether these cytokines can change the development risk of liver cirrhosis found that cytokines reported were controversial.
The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination.
TL;DR: It is concluded that a single booster dose is generally adequate for infants of HBsAg-positive mothers, whereas a further booster dose should be given for non-responders.
8
The association of serum markers of fibrosis and development of liver cirrhosis in chronic hepatitis B patients: A systematic review and meta-analysis
Yongdi Chen,Gaofeng Cai,Chu Zhang,Jun Yao,Zhengting Wang,Zhifang Wang,Chonggao Hu,Huakun Lv,Li Li,Biao Zhou +9 more
TL;DR: Elevated serum hyaluronic acid, laminin, type III precollagen and type IV collagen increased the risk of liver cirrhosis development in chronic hepatitis B patients.
2
Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis
Xiang Lyu,Gaofeng Cai,Kui Liu,Sichao Huang,Jun Yao,Zhenggang Jiang,Zhengting Wang,Zhifang Wang,Yongdi Chen,Huakun Lv,Jianmin Jiang +10 more
TL;DR: The 5-year cumulative incidence rate of hepatocellular carcinoma (HCC) in chronic HBV -infected liver cirrhosis (LC) patients was up to 5%-30%.